Table 2.

Total costs for Euvichol broken down in percentage per external partners funders.

Total expenditure by Eubiologics (17 Million USD)
Korea-Seoul Life Science Fund	20%
Green Cross Corporation	8%
Shinhan-K2 Investment Partners	6%
Global Health Investment Fund	29%
Korea Investment Global Frontier Fund	18%
Eubiologics	19%
Total expenditure by IVI (2.7 Million USD)*
Bill & Melinda Gates Foundation	100%

^*Does not include the unrestricted funding to IVI by i.e. the governments of Korea, Sweden and India.